Cap Analogs
m7GpppApG triammonium salt
Quick view. A trinucleotide mRNA 5' cap analogue supplied in triammonium form for research-use in-vitro RNA synthesis. Exact-form composition and the current specification are confirmed by inquiry. CAS N/A. Catalog target purity: By inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Identifier context
These notes preserve the current catalog identifiers while making their review boundary explicit.
The retained related nucleotide-core identifier is not published as the identifier of the complete triammonium catalog product. Confirm the exact supplied form when requesting a quote.
Core and triammonium formula and molecular-weight values are withheld until an independent exact-form identity binding is available.
Current purity and analytical basis are confirmed by inquiry for the supplied material; no lot-specific OROGO specification is published on this page.
Product profile
m7GpppApG triammonium salt is classified as cap analogs.
m7GpppApG triammonium salt — Trinucleotide cap analogue material for in-vitro RNA synthesis research.
For m7GpppApG triammonium salt, capping outcome depends on polymerase system, cap-to-NTP ratio, transcript design and purification method.
Names and search terms
Confirmed or normalized name variants
- CAP m7G(5')ppp(5')ApG Ammonium Salt
- m7G(5')ppp(5')ApG triammonium
Useful catalog search terms
- m7G(5')ppp(5')ApG
- Cap Analogs
Physicochemical data
| Counterion form | Triammonium |
|---|---|
| Nucleotide shorthand | m7GpppApG |
| Technical data status | Catalog CAS, core and triammonium composition values, and catalog purity are withheld pending independent exact-form confirmation. |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Product-specific evaluation notes
Potential advantages
- Cap analog selection can influence capping efficiency, orientation and downstream translation-related performance.
Method limitations
- Capping outcome depends on polymerase system, cap-to-NTP ratio, transcript design and purification method.
These points describe m7GpppApG triammonium salt or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
ARCA (m2(7,3'-O)GpppG)
Cap Analogs · CAS: 400806-46-4
OR-CA-0002A(5')ppp(5')(2'-OMeA)pG tetraammonium
Cap Analogs · CAS: N/A
OR-CA-0003m7G(UNA)(5')ppp(5')(2'-OMeA)pG triammonium
Cap Analogs · CAS: N/A
OR-CA-0004m7G(5')vppp(5')(2'-OMeA)pG triammonium
Cap Analogs · CAS: 3038327-80-6
OR-CA-0005CAP 6 m7G(LNA)(5')ppp(5')(2'OMeA)pG Triammonium Salt
Cap Analogs · CAS: N/A
OR-CA-0006CAP 7 m7G(HNA)(5')ppp(5')(2'OMeA)pG Ammonium Salt
Cap Analogs · CAS: N/A
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not an OROGO lot specification or product-performance claim.
Request a quote Review request checklist
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.